chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Presented to emergency department on 6/5/2021 with chest pain. He was found to be COVID-19 positive at that time and was treated for pneumonia.  During admission, he was found to be in atrial fibrillation and possible myopericarditis. Patient improved clinically and was discharged to home on 6/14/2021.
A mother reported that her 5 month old son received his first dose of Rota Shield on 6/29/99. 3 to 5 days later, the infant developed constipation with abdominal cramping. As of 8/5/99, the infant was reportedly "improving". Follow-up information was received on 10/14/99 from the physician who did not confirm the mothers report. The physician stated that the infant developed irritability on 7/1/99 and a rash on 7/2/99. The infant recovered.
Headache; body ache; chills; fever; fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 28Apr2021 at 08:45 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included loratadine (CLARITIN), montelukast (MANUFACTURER UNKNOWN), fluticasone propionate (XHANCE) and unspecified birth control pills; all for unspecified indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 28Apr2021 at 16:45, the patient experienced headache, body ache, chills, fever and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, body ache, chills, fever and fatigue was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
pt recv vax & devel fever of 99, chills, sore throat, myalgia & diarrhea;no further info was available @ the date of this report, which was recv from merck;
Intussusception, after vaccine for rotavirus.Reduced w/ barium enema.Dev a 2nd one on 11/19/99 again reduced w/ barium enema(not confirmed by vax provider)
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 07Sep2022 as dose 5 (booster), single (Lot number: GH9694) at the age of 58 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Eggs" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID-19". The patient received PAXLOVID from 23Dec2022 for the treatment of Covid-19.
5 days after receiving first covid vaccine swelling and redness at injection site . site warm to touch and swelling  in left axillary area. Discomfort when raising left arm. Called my primary care physician Dr. and reported . Primary care placed me on Zpak for 5days and also instructed me to take advil 200 mg 2 tabs twice per day. Instructed to call him 1/8/2021 to see if symptoms resolved. He was not sure if vaccine related but due to the swelling at site and swelling in axillary area possible cellulitis. instructed by PCP to report event to VAERS.
Since the vaccine, I have had chronic pain in my ovaries. This pain feels similar to that of the pain you might experience during a heavy menstrual cycle. This pain has been constant for the past 6 weeks.
1st shot: immediate swelling in throat/lungs. Used my albuterol inhaler.  Benedryl onc home 2nd shot:   Doctor advise inhaler and benedryl use 2 hours BEFORE 2nd shot.  Shot went ok but throat, lungs/tongue swell when drugs wire off.  Severe reaction.   Used Benedryl, inhaler/nebulizer for days . Still left lung pain and asthma  symptoms.
Pain left arm near the elbow (lower on the inside) in the past 3 weeks, diarrhea every day since I got vaccinated. The change has been significant. Palpitations have increased without doing anything, body discomfort difficult to explain. A lot of fatigue and it has not decreased in days.
Sore arm after first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm after first dose) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm after first dose). At the time of the report, PAIN IN EXTREMITY (Sore arm after first dose) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No relevant concomitant medications were reported. No treatment information was provided. The reactions settled in a few days. No further issues were reported.   This case was linked to MOD-2021-024371 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: TCR Attached
PATIENT PRESENTED WITH REDNESS AND SWELLING THAT EXTENDED FROM SHOULDER TO UNDER ARM PIT. SWELLING WAS MINIMAL. PATIENT WAS INSTRUCTED TO TAKE BENADRYL AND TO KEEP A COLD COMPRESS (ICE PACK) ON AREA AND TO CALL PHARMACY IF SWELLING OR REDNESS WORSENED OR DID NOT BEGIN TO RESOLVE
Local reaction to vaccine site on upper left arm - redness and wamrth present with mild swelling. No induration. Orapred 15mg/5ml 1 tsp PO given at visit and prescription for same dose x 3 more days given.
PT C/O ITCHING THROUGHOUT ENTIRE BODY. NO RASH NOTED, MINOR REDNESS TO ARMS NOTED. 38 YO FEMALE GIVEN 25 MG DIPHENHYDRAMINE X 2 TABS.
Tingling pain all the way down my arm, and into my hand starting a couple of days after my vaccine. Gardasil was the only vaccine in that arm. It got a little bit better; I was doing heavy lifting this weekend (4/25), and now my wrist and hand have the same tingling pain all over again. It's a distinct feeling, and my left side does not have it.
Left ear hurt 11 pm 1-25-21; Violent pain/claws ripping flesh off half of face/head 2 am 1/26/21; non-amblitory, could not support weight, major balance issues. Televisit 1/26/21=earache. Blacked out cold 5 min, non responsice 30 min 2 am  1/26/21; woke with Bell's Palsey; Ddumb televisit 1/28/21=BP. Urgent Care visit-EKG (normal), bloodwork, urine lab work. 2/1/21 Saw NEURO = MRI brain w/contrast to rule out cancer (2/4/21; Two weeks of solid hallucinations 24/7. Horrendous balance issues-almost non-amblitory from onset 1/26/21 to present. Lost 9 pounds in 2 weeks.(I was 104 now 95 pounds). I was walking 5 mi a day, walked 1/24/21, healthy.  Devastating pain to left side of head/face, esp ear. PAIN
Site: Pain at Injection Site-Severe, Additional Details: tingling down the arm as well
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age.  No information was provided regarding medical history, concurrent conditions, or concomitant medications. In or about 2015, a pharmacist at a pharmacy administered the ZOSTAVAX to the patient (dose, route, and lot # not provided). The patient's healthcare provider recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions.  In or about November 2016, the patient was treated by a physician for shingles.  He was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries.  As a direct and proximate result of ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages.  The outcome of the events were unknown.  Causality assessment was related. Additional information has been requested.
day after getting the 1st dose she got a headache/chills/low temp/couldn't more left arm/arm, neck and shoulder pain
chills, fever, temp 102 for about 8 hours then dissipated. No treatment needed
The patient was in the office with his 4 year old sister who was also receiving vaccines.  The 14 month patient was administered his sisters 4 year old Quadracel instead of the Hep A vaccine that was planned.  This resulted in the 14 month old patient receiving a higher dose of DTAP and IPV which is recommended for 4 years and above.
Little to no pain for several hours after shot, small initial pain and 1" of selling around injection site 6 hours later. 14 hours later (after sleep), moderate exhaustion, feverish, light sweating and joint/body aches. Fever broke after approx. 24 hours from shot, arm swelling slightly larger area but more dispersed with mild exhaustion and moderate joint/body ache continues 48 hours later.
Injection site reaction, redness and swelling with pain to touch. Pt Sebaceous cyst at the injection site.
At 3:00 PM today, received telephone call from client's father, reporting that patient had a "seizure" about 1 hour after receiving vaccines. Described that patient felt light-headed and reported to be dizzy, then laid head down and "appeared to begin convulsing." Reports to have contacted child's pediatrician who encouraged they continue to monitor patient and notify us about the incident. Father denies any Hx/O of seizures for the patient, and admits he and child's mother are whom determined this episode a "seizure."
no other AE; an expired dose was administered to a patient; This spontaneous report was received from a medical assistant, referring to a patient with unknown age and gender. The patient's concomitant therapy, concurrent conditions, medical history and drug reactions/allergies were not reported.  On 17-MAY-2023, the patient was vaccinated with an expired dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (thimerosal free) (1 dosage form, lot number T035865 has been verified to be a valid lot number, expiration date was reported as 28-APR-2023, route and anatomical location were not provided) for prophylaxis (expired product administered). No other adverse event (AE) occurred (no adverse event) and the hepatitis b vaccine (recombinant) (RECOMBIVAX HB) did not have any temperature excursions prior to administration.
Inflammed lymph nodes in the arm that it was injected, moderate pain, unable to sleep, weakness in my arm.  Duration 4 days and still unsolved.
17DEC92 fever 100.8 ax; 18DEC92 lazy, temp still sl elevated 19DEC92 103-104 ax acted achy; 20DEC no fever; grabbing head, rubbing eyes; seen by MD 21DEC92; 20DEC92 rash;
expired Ipol was inadvertently administered to a 2 year old/no ae; Initial information was received on 05-May-2020 regarding an unsolicited valid non-serious case from a other health professional.  This case involves a two-year-old male patient who was inadvertently administered IPV (VERO) [IPOL].  Medical history, medical treatment, vaccination and family history were not provided.  On unknown date, the patient received concomitant medications PREVNAR 13.  On 05-May-2020, the patient received a second 0.5 ml dose of suspect IPV (VERO) [lot P1A251M, expiry date: 02-May-202] via an intramuscular route at the left deltoid.  It was a case of actual medication error due to expired vaccine used.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Information has been received from a physician concerning a female who was vaccinated with a dose of GARDASIL. One or two months after the GARDASIL dose the patient experienced optic neuritis. This is one of two reports from the same source. Additional information is not expected.
Pale, diaphoretic, dizziness, pseudo seizure. Pt placed in reverse Trendelenburg on the floor with feet in a chair, vital signs taken and patient was given time to recover.Patient left building on own accord without issue. Pt informed to watch for further issues and contact 911 if needed;  pt stated understanding.
Patient states severe reaction within 1 hr of administration. She was very dizziness and fell over. She felt "miserable". She had a temperature of 100.1 degrees. No permanent injury. This lasted for 2-3 days.
This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Received dose from vial that had black particulates in previous syringe) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination. No Medical History information was reported. On 01-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Dec-2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Received dose from vial that had black particulates in previous syringe). On 01-Dec-2021, POOR QUALITY PRODUCT ADMINISTERED (Received dose from vial that had black particulates in previous syringe) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant information was not provided. It was reported that the pharmacist thought that she got a rubber stopper in the syringe. Then, she looked better and there were like black specks floating in it. Pharmacist also referred to them as black things. Treatment information was not provided.
Right arm, inner and triceps area swollen down to elbow with red rash, tingling and numbness down through hand and fingers. Frequent pain and itching.
After the vaccine I had really sore left arm the next day. On the following weekend I had a severe vomiting that caused me to go to the urgent care to get prescription for the nausea and vomiting that was an ongoing episode for about 6-7 hours throughout the whole night. I had a headache, fatigue and it resolved within 48 hours.
Patient started with a heavy feeling in chest Vital signs done elevated BP 156/65, HR 72, SpO2 97%. patient felt better return to sit with family, but then became SOB w/ tightness in chest 50 mg Benadryl and 2 L/m O2 applied. patient's color returned to facial feature, patient feeling better BP elevated second presentation to 168/64 HR 71, SpO2 100% 2L/m NC. Patient is now improving with BP 158/63, HR 72, RR 20, SpO2 97% ra. 1200 hr BP 155/65,
MULTIPLE SCLEROSIS; Considerable health issues since being vaccinated; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MULTIPLE SCLEROSIS (MULTIPLE SCLEROSIS) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MULTIPLE SCLEROSIS (MULTIPLE SCLEROSIS) (seriousness criterion medically significant) and VACCINATION COMPLICATION (Considerable health issues since being vaccinated). At the time of the report, MULTIPLE SCLEROSIS (MULTIPLE SCLEROSIS) and VACCINATION COMPLICATION (Considerable health issues since being vaccinated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.   Very limited information regarding this events has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested.
lied in bed and slept; very dizzy; weakness; tired; This spontaneous report was received from a pharmacist via Pfizer and refers to a 42-year-old female patient. On an unknown date in 2017, the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) (exact dose, site and route of administration, lot# and expiration date were not reported) for prophylaxis. After the vaccination, she felt very dizzy, she was tired, had weakness and lied in bed nd slept. The outcome of the events was not reported. The relatedness between the events and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) was not provided.
2 wks so far; nausea, h/a, cold & flu sx, lethargic;
05/14/2003 fever, headache. 05/15/2003 back ache, sore throat> self medicated with Motrin 800mg PO apprx 96 hours w/o relief. Was seen in ED on 05/16/2003. Discharges "back pain". Rx for Motrin and Vicodin given.
Also received MUMPS Reaction - stiffness in both hands, rash/bump on chest and one on  left arm
fever 102, vomiting, rash on body;fever 25SEP97-28SEP97;vomiting 27SEP97;rash 26SEP97;coughing 29SEP97;
OK FOR 2 DAYS AFTER 2ND SHOOT THEN SEVERE PAIN DEVELOPED IN RIGHT HIP AND LEG MUSCLES AND THEN SPREAD TO OTHER LEG OVER 1-2 DAY PERIOD.  SEVERE PAIN CONTINUES NOW IN BOTH LEGS AND HAS NOT SIGNIFICANTLY DIMINISHED.  PAIN HAS BEEN AND CONTINUES TO BE SUFFICIENT TO INTERRUPT DAILY ACTIVITY AND SLEEP.  TEMPORARY MINOR RELIEF ACHIEVED WITH MAX DOSES OF OTC PAIN MEDS BUT STILL DISRUPTIVE.  INTEND TO CONSULT WITH FAMILY DOCTOR TOMORROW.  VERY UNPLEASANT!
Inflammation of the eye, redness, vision impairment, and pain due to uveitis.  Symptoms developed slowly over several weeks until unbearable and treated with prednisolone acetate eye drops.  The symptoms have improved, but have not completely healed.  Vision impairment has continued.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 50-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 07May2022 at 12:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 50 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "MS" (unspecified if ongoing); "drug Allergy" (unspecified if ongoing), notes: Name of Drug as Reported: No. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2022, outcome "unknown" and all described as "COVID 19 Treatment"; DISEASE RECURRENCE (medically significant) with onset 27Aug2022, outcome "recovering", described as "Rebound case. I have now been sick for 15 days". Therapeutic measures were taken as a result of drug ineffective, covid-19 from 21Aug2022 to 25Aug2022. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 10-NOV-2015, the patient was vaccinated with improperly stored RECOMBIVAX HB (exposed to the following temperatures and cumulative time frames colder than 36F: In September of 2015, the coldest temperature was 34F for 346.7 hours (over 14 days); In October of 2015, the coldest temperature was 34F for 492.6 hours for a total of 839.3 hours (35 days); In November of 2015, the coldest temperature was 34F for 192 hours, for a total of 1,031.3 hours (43 days)) with lot number: L018500, expiry date: 13-APR-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Drank a beer and took 5mg melatonin at 1000pm Apr 23 Chills from about 1100pm Apr 23 to 300am Apr 24 Got up from bed at 430am to urinate. Felt light-headed. Passed out for maybe 2-5 seconds and collapsed on way back to bed. Slept until about 900am and felt fairly normal when I got up. Just tired for rest of the day on Apr 24.
Anaphylactic shock, could not even make it home before diarrhea occurred. For 10 weeks now - extreme diarrhea - extreme fatigue - random vomiting.
Given client expired Rotavirus; had client to wait 15 min after med given; no problem noted. Inform Dr. and supervisor. Will call or send letter to revaccinate.
Rash and raised bumps 1.5?-2? from the injection site. Itching, tenderness
On 07/15/2021 a J & J Vaccine vial was opened at 02:48PM. Three doses were taken out. Vial  was left in Refrigerator and not wasted at the end of the Day.  On 07/16/2021 a dose was taken out of same vial of 07/15/2021 and administered at about 08:30AM.  At 05:00PM 07/16/2021 a patient came in to get a J&J vaccine and we found out what happened.  A new vial was opened and the patient (new) received their dose.  the New vial was wasted at the end of the day.